Difference between revisions of "Fibrocystic breast changes"

From patholines.org
Jump to navigation Jump to search
m (heights)
Line 9: Line 9:
 
Types:
 
Types:
 
<gallery mode=packed heights=220>
 
<gallery mode=packed heights=220>
File:Histopathology of sclerosing adenosis of the breast.jpg|'''Sclerosing adenosis''', with an increase in glandular elements in addition to stromal proliferation that distorts and compresses glands.<ref name=PathologyOutlines>{{cite web|url=https://www.pathologyoutlines.com/topic/breastsclerosingadenosis.html|title=Breast - Fibrocystic changes - Sclerosing adenosis|author=Jaya Ruth Asirvatham, M.B.B.S., Julie M. Jorns, M.D.|website=Pathology Outlines}} Topic Completed: 1 January 2015. Minor changes: 31 December 2020</ref>
+
File:Histopathology of sclerosing adenosis of the breast.jpg|'''Sclerosing adenosis''', with an increase in glandular elements in addition to stromal proliferation that distorts and compresses glands.<ref name=PathologyOutlines-fibrocystic>{{cite web|url=https://www.pathologyoutlines.com/topic/breastsclerosingadenosis.html|title=Breast - Fibrocystic changes - Sclerosing adenosis|author=Jaya Ruth Asirvatham, M.B.B.S., Julie M. Jorns, M.D.|website=Pathology Outlines}} Topic Completed: 1 January 2015. Minor changes: 31 December 2020</ref>
 
File:Histopathology of a radial scar of the breast.jpg|A '''radial scar''' of the breast, seen as a fibroelastic stroma and entrapped glands radiating outward.
 
File:Histopathology of a radial scar of the breast.jpg|A '''radial scar''' of the breast, seen as a fibroelastic stroma and entrapped glands radiating outward.
 
</gallery>
 
</gallery>

Revision as of 17:57, 19 June 2022

Author: Mikael Häggström [note 1]

Presentations

Microscopic examination

Types:

Differential diagnosis

Sclerosing adenosis may look similar to invasive ductal carcinoma (IDC), but IDC will:[2]

  • Not be lobular at low power
  • Have marked cellular atypia
  • Have no myoepithelial cells surrounding ducts.

When unsure, perform immunohistochemistry for myoepithelial markers (preferably p63 and calponin in breast lesions):

Immunostain with a myoepithelial marker (calponin) in sclerosing adenosis, showing myoepithelial cells surrounding the ducts, thereby excluding invasive carcinoma.

Notes

  1. For a full list of contributors, see article history. Creators of images are attributed at the image description pages, seen by clicking on the images. See Patholines:Authorship for details.

Main page

References

  1. Jaya Ruth Asirvatham, M.B.B.S., Julie M. Jorns, M.D.. Breast - Fibrocystic changes - Sclerosing adenosis. Pathology Outlines. Topic Completed: 1 January 2015. Minor changes: 31 December 2020
  2. Cite error: Invalid <ref> tag; no text was provided for refs named PathologyOutlines

Image sources